# Multidisciplinary Care Program to Secure MEdication Therapy for HematoLOgy Patients Receiving Injectable Anticancer Drugs

> **NCT05350930** · — · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 38 (actual)

## Conditions studied

- Chemotherapy Effect
- G-CHOP Chemotherapy
- R-CHOP Chemotherapy

## Interventions

- **OTHER:** Assessment of patient satisfaction regarding tele-consultation
- **OTHER:** Literacy questionnaire
- **OTHER:** Collection of socio-demographic characteristics
- **OTHER:** Assessment of patient knowledge on chemotherapy side effects and support medications
- **OTHER:** Assessment of patient satisfaction on pharmaceutical follow-up

## Key facts

- **NCT ID:** NCT05350930
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-09
- **Primary completion:** 2023-02-15
- **Final completion:** 2023-02-15
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2025-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05350930

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05350930, "Multidisciplinary Care Program to Secure MEdication Therapy for HematoLOgy Patients Receiving Injectable Anticancer Drugs". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05350930. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*